Sign in

You're signed outSign in or to get full access.

J. Kermit Anderson

Director at ADIAL PHARMACEUTICALS
Board

About J. Kermit Anderson

Independent director of Adial Pharmaceuticals since February 2015; age 74; currently Class III director standing for re‑election in 2024 with a term to 2027 if re‑elected . He is VP and CFO at Cumberland Development Co. (family office investing across minerals exploration, life sciences, real estate) since 2007, with 40+ years in finance, planning, GAAP reporting, and corporate development roles at Massey Energy, AMVEST, and Cumberland Resources, including work on company sales and startups; BS‑BA from West Virginia University (1972) . The Board has determined he is independent under Nasdaq/SEC rules .

Past Roles

OrganizationRoleTenureCommittees/Impact
Cumberland Development Co.VP & Chief Financial OfficerSince 2007 Oversees investments across minerals exploration, life sciences, and real estate for a family office
Massey EnergyFinancial/Development rolesNot disclosed Worked on company sale; startups experience
AMVESTFinancial/Development rolesNot disclosed Startups and expansion into new business area; worked on sale
Cumberland Resources CorporationFinancial/Development rolesNot disclosed Worked on company sale

External Roles

OrganizationRoleTenureNotes
Other public company boardsNone disclosedNo other public company directorships listed for Anderson in the proxy
Private/Non‑profit boardsNone disclosedNo additional board roles disclosed beyond Cumberland Development Co. (private)

Board Governance

  • Committees: Audit Committee member; Compensation Committee chair; not on Nominating & Corporate Governance .
  • Independence: Board determined Anderson is independent under Nasdaq and SEC rules; both Audit and Compensation Committees comprise independent directors .
  • Attendance: Board held 12 meetings in 2023; each incumbent director attended ≥75% of Board and committee meetings; Audit (3), Compensation (2), Nominating & Corporate Governance (1), Pricing (3) meetings in 2023; all six directors attended the 2023 annual meeting (five in person, one telephonically) .
  • Leadership: Lead Independent Director is Kevin Schuyler, who presides over executive sessions and liaises with management .
  • Policies: Anti‑hedging and anti‑pledging policy prohibits short sales, hedging and pledging by directors and other covered persons; equity grants are made at regularly scheduled Board meetings with exercise price at the market closing price and time‑based vesting; no grant timing to take advantage of undisclosed information .
  • Related‑party oversight: Audit Committee reviews/approves related person transactions per charter and Item 404; oversees cybersecurity and risk .

Fixed Compensation

YearCash Fees ($)Stock Awards ($)Option Awards ($)Total ($)
202347,000 12,219 59,219

Director cash retainer schedule (in effect during 2023):

RoleBoard ($)Audit Committee ($)Compensation Committee ($)Nominating & Governance ($)
Chair31,200 16,000 11,000 8,000
Member24,000 8,000 6,000 4,000

Performance Compensation

Grant/StatusTypeSharesExercise PriceVestingFair Value/Notes
Mar 25, 2024 director grantStock options12,000 $1.35 Vests over 3 years Annual director grant; uniform program
Outstanding at 12/31/2023Stock options7,823 Aggregate outstanding options held by Anderson as of FY‑end
2023 Option awardsStock optionsFair value recognized: $12,219

Performance metrics tied to director pay:

Compensation ElementPerformance MetricTargetOutcomePayout Impact
Director equity grants (options)None disclosed (time‑vested only) N/AN/AN/A

Other Directorships & Interlocks

CompanyRoleCommittee RolesInterlocks/Conflicts
None disclosedNo other public company board interlocks disclosed for Anderson

Expertise & Qualifications

  • Deep finance and corporate development experience across public and private companies, including financial planning/reporting, accounting, forecasting, pricing, GAAP reporting, contract negotiations, and benefits/compensation .
  • Extensive transactions background (major sales and acquisitions; startup work at energy companies) .
  • Education: BS‑BA, West Virginia University (1972) .

Equity Ownership

HolderShares Beneficially Owned% of OutstandingComponents/Notes
J. Kermit Anderson9,790 <1% Includes options to purchase 9,790 shares that will vest within 60 days of Sep 26, 2024; total option grants to purchase 19,823 shares . Company policy prohibits hedging and pledging of company stock by directors .

Governance Assessment

  • Strengths: Independent director; chairs Compensation Committee and serves on Audit Committee, providing pay oversight and financial governance ; robust anti‑hedging/pledging policy ; Board operates with lead independent director and executive sessions ; directors met attendance thresholds and were engaged at the annual meeting ; Audit Committee actively oversees risk, internal control, independence of auditors, and related‑party transactions .
  • Alignment: Receives a mix of cash fees and time‑vested options; 2024 option grant of 12,000 aligns director incentives with shareholders over a three‑year vesting horizon . Beneficial ownership is modest (<1%), which may temper “skin‑in‑the‑game” signals .
  • Watch‑items: No performance metrics tied to director compensation (options are time‑vested) ; modest personal holdings relative to float . Company has related‑party transactions with other insiders (e.g., consultancy and services involving Tony Goodman/Keswick; Purnovate/Adovate option and sale with former CEO William Stilley), though these are overseen and disclosed; none specifically link to Anderson .
  • Policy safeguards: Executive clawback policy for incentive compensation in case of accounting restatement; positive governance signal even though targeted to executives .

RED FLAGS: None specific to Anderson disclosed (no pledging permitted; no related‑party transactions involving Anderson disclosed; attendance thresholds met) .